The Molecular Biology and Genomics Core of the HU CFAR will build upon the combined strengths of the pre-existing Virology/Molecular Biology core and the Genomics program (initiated in 2007). The primary goal of the new Genomics core is to enable CFAR investigators by providing access to and support with state-ofthe- art genomic technologies (including but not limited to viral sequencing, host genomics, gene expression profiling) for HIV/AIDS research projects. We will do this by offering guidance to those who wish to initiate genomics projects or incorporate genomic techniques into their research, and by referring investigators to key scientists with relevant expertise in the local genomics community, including those at the Broad Institute of Harvard and MIT. In addition, we will continue to provide services that have been offered previously at the Dana-Farber Cancer Institute Molecular Biology Core Facilities (through the pre-existing HU CFAR Virology/Molecular Biology core). Dr Paul de Bakker (currently HU CFAR Genomics Program Director) will be the new core director.

Public Health Relevance

Genetics and genomics have become indispensable tools to develop a better understanding of HIV biology, specifically, how HIV interacts with the immune system, how it exhausts the immune system, and ultimately, how it leads to AIDS. We are allowing Harvard scientists to access these tools and maximize the impact of their research.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI060354-10
Application #
8523743
Study Section
Special Emphasis Panel (ZAI1-SV-A)
Project Start
Project End
Budget Start
2013-08-01
Budget End
2014-07-31
Support Year
10
Fiscal Year
2013
Total Cost
$284,645
Indirect Cost
$50,600
Name
Harvard University
Department
Type
DUNS #
082359691
City
Cambridge
State
MA
Country
United States
Zip Code
02138
Andersen, Lena S; Magidson, Jessica F; O'Cleirigh, Conall et al. (2018) A pilot study of a nurse-delivered cognitive behavioral therapy intervention (Ziphamandla) for adherence and depression in HIV in South Africa. J Health Psychol 23:776-787
North, Crystal M; Allen, Joseph G; Okello, Samson et al. (2018) HIV Infection, Pulmonary Tuberculosis, and COPD in Rural Uganda: A Cross-Sectional Study. Lung 196:49-57
Siedner, Mark J; Baisley, Kathy; Orne-Gliemann, Joanna et al. (2018) Linkage to primary care after home-based blood pressure screening in rural KwaZulu-Natal, South Africa: a population-based cohort study. BMJ Open 8:e023369
Foldyna, Borek; Fourman, Lindsay T; Lu, Michael T et al. (2018) Sex Differences in Subclinical Coronary Atherosclerotic Plaque Among Individuals With HIV on Antiretroviral Therapy. J Acquir Immune Defic Syndr 78:421-428
Kimizuka, Yoshifumi; Katagiri, Wataru; Locascio, Joseph J et al. (2018) Brief Exposure of Skin to Near-Infrared Laser Modulates Mast Cell Function and Augments the Immune Response. J Immunol 201:3587-3603
Ngonzi, Joseph; Bebell, Lisa M; Fajardo, Yarine et al. (2018) Incidence of postpartum infection, outcomes and associated risk factors at Mbarara regional referral hospital in Uganda. BMC Pregnancy Childbirth 18:270
Gogia, Shawnbir; Coromilas, Alexandra; Regan, Susan et al. (2018) Cardiovascular Risk Profile of Transgender Women With HIV: A US Health Care Database Study. J Acquir Immune Defic Syndr 79:e39-e41
Draz, Mohamed Shehata; Moazeni, Maryam; Venkataramani, Manasa et al. (2018) Hybrid Paper-Plastic Microchip for Flexible and High-Performance Point-of-Care Diagnostics. Adv Funct Mater 28:
Hill, Alison L; Rosenbloom, Daniel I S; Nowak, Martin A et al. (2018) Insight into treatment of HIV infection from viral dynamics models. Immunol Rev 285:9-25
Milligan, Michael G; Bigger, Elizabeth; Abramson, Jeremy S et al. (2018) Impact of HIV Infection on the Clinical Presentation and Survival of Non-Hodgkin Lymphoma: A Prospective Observational Study From Botswana. J Glob Oncol :1-11

Showing the most recent 10 out of 1030 publications